TranS1 Appoints Jeffrey Fischgrund, M.D. to Board of Directors
4/5/2012 9:46:28 AM
WILMINGTON, N.C., April 5, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON), a medical device company focused on designing, developing and marketing spine products to treat degenerative conditions of the spine affecting the lower lumbar region, announced today that it has appointed Jeffrey Fischgrund, M.D. to serve on its Board of Directors. Dr. Fischgrund currently serves as Professor of Orthopaedic Surgery at The Oakland University School of Medicine, at William Beaumont Hospital in Royal Oak, MI.
comments powered by